Skip to content

Author

B. Podesser

We have 2 of 406 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Empagliflozin promotes reverse remodeling via cardiometabolic reprogramming in established pressure-overload left ventricular hypertrophy

Left ventricular hypertrophy (LVH) due to chronic pressure overload is a major precursor of heart failure (HF) and is characterized by metabolic inflexibility and mitochondrial dysfunction. Sodium–glucose cotransporter-2 inhibitors (SGLT2i) improve HF outcomes; however, their myocardial mechanisms in LVH remain i...

M. Ernst, A. A. Goncalves, C. Dostal et al. · 0 citations
Open access Oct 2026

Comprehensive cardiac, vascular, and pulmonary characterization of a cardiometabolic HFpEF model.

BACKGROUND Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous syndrome in which translational progress is limited by experimental models that insufficiently reflect the cardiometabolic phenotype while affecting endogenous endothelial function. We aimed to characterize a cardiometabolic "two-hit"...

I. Aykac, Christoph A. Baumgartner, O. Hamza et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.